In the Molecular Programming Project (MPP) at the California Institute of Technology and the University of Washington, scientists will develop new computer science principles for programming information-bearing molecules like DNA and RNA to create artificial biomolecular programs of similar complexity.
The Nanosystems Biology Cancer Center (NSBCC) is organized to take advantage of the state-of-the-art in chemistry, materials, and physics of nanotechnology science and engineering, the state-of-the-art in systems biology approach to health and disease, and the state-of-the-art in the science, technology, and clinical applications of cancer biology.
Motivated by the goal of encoding arbitrary mechanical function into nucleic acid sequences, the lab is working to develop computational algorithms for the analysis and design of equilibrium and kinetic properties of nucleic acid systems. In the laboratory, we are focused on constructing molecular sensors, transducers and motors for therapeutic, bioimaging, and transport applications.
The University of California, Los Angeles and University of California, Santa Barbara have joined to build the California NanoSystems Institute (CNSI), which will facilitate a multidisciplinary approach to develop the information, biomedical, and manufacturing technologies that will dominate science and the economy in the 21st century
The lab's goal is to understand the fundamental design principles of cellular control systems and to apply these principles to engineer cells or cell-like devices with novel, 'smart' therapeutic functions.
The CCNE's goal is goal is to develop and validate nanotechnology so that one will eventually be able to predict which patients will likely respond to a specific anti-cancer therapy and to monitor their response to therapy.
The Center for Cell Control is working to first utilize systems control, with therapeutic intent, to determine the parameters for guiding the cell to a directed phenotype/genotype which will then be followed by in depth study, using nanoscale modalities, of the path by which this desired state is achieved. This approach will enable engineering systems that can be applied towards the regulation of a spectrum of cellular functions, such as cancer eradication, controlling viral infection onset, and stem cell differentiation.
The goal of COINS is to develop and integrate cutting-edge nanotechnologies into a versatile platform with various ultra-sensitive, ultra-selective, self-powering, mobile, wirelessly communicating detection applications.
FENA aims to create and investigate new nano-engineered functional materials and devices, and novel structural and computational architectures for new information processing systems beyond the limits of conventional CMOS technology.
City of Hope is a research hospital that has started a multidisciplinary collaboration with the National Aeronautics and Space Administration’s Jet Propulsion Laboratory (JPL) to pursue nanomedicine therapies.
The FlexTech Alliance is the only organization headquartered in North America exclusively devoted to fostering the growth, profitability and success of the electronic display and flexible, printed electronics supply chain. Leveraging its rich history in promoting the display industry as the U.S. Display Consortium, the FlexTech Alliance offers expanded collaboration between and among industry, academia, and research organizations for advancing displays and flexible, printed electronics from R&D to commercialization.
The Girvan Institute of Technology is a non-profit, public benefit corporation chartered to facilitate the transfer, development and commercialization of technologies and to foster the growth of early-stage high-tech companies.